Electrochemotherapy for Recurrent Vulvar Cancer
A phase 2 trial of Electrochemotherapy in Vulvar cancer, run by Institute of Oncology Ljubljana, now recruiting.
Overview
Electrochemotherapy for Recurrent Vulvar Cancer is a phase 2 interventional study registered as NCT07443475 by Institute of Oncology Ljubljana, with 13 participants planned, started 2021-09-01 and due to reach its primary completion in 2026-08-31. Interventions recorded: Electrochemotherapy (ECT). Conditions recorded: Vulvar Cancer, Recurrent Vulvar Cancer.
Linked to the technology Electrochemotherapy because the registry names it ("electrochemotherapy") among its interventions and Vulvar cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialElectrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
Shares Electrochemotherapy, Vulvar cancer and the tag pipeline.
- TrialElectrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects
Shares Electrochemotherapy and the tag pipeline.
- TrialPhase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Shares Vulvar cancer and the tag pipeline.
- TreatmentLorigerlimab
Shares Vulvar cancer and the tag pipeline.